Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
27.98
-0.78 (-2.71%)
At close: Mar 9, 2026, 4:00 PM EDT
29.00
+1.02 (3.65%)
After-hours: Mar 9, 2026, 4:03 PM EDT
Forte Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 496 | 145 | 30 | 21 | 32 | 467 | |
| Market Cap Growth | 625.54% | 386.30% | 42.17% | -33.49% | -93.24% | - | |
| Enterprise Value | 424 | 129 | -16 | -23 | -14 | 447 | |
| Last Close Price | 28.76 | 22.71 | 20.54 | 25.00 | 53.50 | 910.25 | |
| PB Ratio | 6.10 | 2.77 | 0.85 | 0.54 | 0.76 | 7.92 | |
| P/TBV Ratio | 6.16 | 2.77 | 0.85 | 0.54 | 0.76 | 7.92 | |
| Net Debt / Equity Ratio | -1.11 | -1.11 | -1.05 | -1.06 | -1.01 | -1.00 | |
| Net Debt / EBITDA Ratio | 1.75 | 1.60 | 1.14 | 2.97 | 1.96 | 4.15 | |
| Net Debt / FCF Ratio | 2.10 | 1.90 | 1.29 | 5.02 | 2.52 | 3.19 | |
| Quick Ratio | 7.23 | 6.43 | 10.13 | 12.93 | 23.92 | 26.01 | |
| Current Ratio | 7.34 | 6.76 | 10.46 | 13.06 | 24.19 | 26.52 | |
| Return on Equity (ROE) | -110.72% | -80.82% | -84.92% | -34.54% | -43.19% | -143.64% | |
| Return on Assets (ROA) | -58.07% | -45.51% | -50.15% | -20.36% | -25.69% | -25.81% | |
| Return on Capital Employed (ROCE) | -63.50% | -69.70% | -92.00% | -35.80% | -51.70% | -24.10% | |
| Earnings Yield | -10.00% | -24.44% | -105.42% | -66.09% | -68.75% | -9.95% | |
| FCF Yield | -8.61% | -21.20% | -96.44% | -38.98% | -52.82% | -3.94% | |
| Buyback Yield / Dilution | -538.39% | -130.90% | -81.61% | -24.45% | -89.81% | -249.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.